Stoke Therapeutics
STOK
STOK
118 hedge funds and large institutions have $715M invested in Stoke Therapeutics in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 36 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
+4
Holders Change %
+3.51%
% of All Funds
1.71%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
39
Reduced
36
Closed
19
Calls
$94K
Puts
$475K
Net Calls
-$381K
Net Calls Change
-$492K
Top Buyers
| 1 |
Morgan Stanley
New York
|
$51.7M |
| 2 |
Marshall Wace
London,
United Kingdom
|
$20.5M |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
$5.89M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$5.68M |
| 5 |
RI
RTW Investments
New York
|
$57.2M |
